Overview

Meda Pharmaceuticals is a subsidiary of Mylan N.V., focusing on specialty pharmaceuticals. The company develops and markets a broad range of products, prioritizing those that meet unmet medical needs in various therapeutic areas.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Meda AB in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.